Back to Search Start Over

[Treatment of malignant effusion].

Authors :
Efteev LA
Esakov YS
Blinova EV
Bazylyuk AV
Blinov KD
Source :
Khirurgiia [Khirurgiia (Mosk)] 2024 (7), pp. 141-147.
Publication Year :
2024

Abstract

Malignant effusion complicates more than 15% of all cancers in delayed stages of progression. The most common causes of metastatic pleuritis are lung cancer, breast cancer, ovarian cancer, lymphoproliferative diseases or dissemination of gastrointestinal tumors. Malignant effusion is associated with negative prognosis for overall survival regardless of etiology of tumor, significantly complicates the course of the underlying disease, impairs life quality and complicates treatment. Despite various methods for pleural cavity obliteration in recurrent metastatic pleuritis, there is still no a uniform approach to choosing the optimal treatment strategy. We analyzed the main methods of conservative and surgical treatment of recurrent metastatic pleuritic regarding efficacy, risk of recurrence and reproducibility.

Details

Language :
Russian
ISSN :
0023-1207
Issue :
7
Database :
MEDLINE
Journal :
Khirurgiia
Publication Type :
Academic Journal
Accession number :
39008708
Full Text :
https://doi.org/10.17116/hirurgia2024071141